Literature DB >> 26813951

Prostate cancer: MCT4 is a novel target for prostate cancer.

Rebecca Kelsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26813951     DOI： 10.1038/nrurol.2016.14

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer.

Authors:  Stephen Yiu Chuen Choi; Hui Xue; Rebecca Wu; Ladan Fazli; Dong Lin; Colin C Collins; Martin E Gleave; Peter W Gout; Yuzhuo Wang
Journal:  Clin Cancer Res       Date:  2016-01-11       Impact factor: 12.531
  1 in total
  1 in total

1.  MCT4 is induced by metastasis-enhancing pathogenic mitochondrial NADH dehydrogenase gene mutations and can be a therapeutic target.

Authors:  Keizo Takenaga; Nobuko Koshikawa; Miho Akimoto; Yasutoshi Tatsumi; Jason Lin; Makiko Itami; Hiroki Nagase
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.